Concepedia
9
Publications
145
Citations
H-Index
2014
Active since
Affiliations
Janssen (United States)(Current)
Janssen Scientific Affairs (United States)
Janssen (Belgium)
Analysis Group (United States)
University of New Mexico
Akshay Kharat is an author at Janssen (United States).
Publications per year
2014–2024
Real-world effectiveness and safety of rivaroxaban versus warfarin among non-valvular atrial fibrillation patients with obesity in a US population
Jeffrey S. Berger, François Laliberté, Akshay Kharat et al. · Current Medical Research and Opinion · 2021 · 25 citations · Full text
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma
Sundar Jagannath, N.R. Joseph, Concetta Crivera et al. · Oncology and Therapy · 2023 · 25 citations · Full text
Assessing Disparities in the Receipt of Inhaled Corticosteroid Prescriptions for Asthma by Hispanic and Non-Hispanic White Patients
Akshay Kharat, Matthew E. Borrego, Dennis W. Raisch et al. · Annals of the American Thoracic Society · 2014 · 22 citations
Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy
Mark J. Alberts, Jinghua He, Akshay Kharat et al. · American Journal of Cardiovascular Drugs · 2022 · 15 citations · Full text
Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization
Urvi Desai, Akshay Kharat, Connie N. Hess et al. · Annals of Vascular Surgery · 2021 · 14 citations · Full text
Rows per page
1–5 of 9